Peptides targeting the hallmarks of aging, mitochondrial function, DNA repair, and cellular energy.
NAD+ replenishes a coenzyme central to cellular energy and DNA repair that declines steeply with age, while MOTS-c, a mitochondria-derived peptide, regulates metabolic flexibility and insulin sensitivity. Epithalon rounds out the category with telomere-supporting research.

Long-acting amylin analogue that enhances satiety; often paired with semaglutide (CagriSema) for additive fat loss.
Evidence Level

Neuropeptide preparation studied for neuroprotection, stroke recovery, and cognitive enhancement.
Evidence Level

Extended GHRH analogue, the perfect stack partner for Ipamorelin.
Evidence Level

Telomerase-activating tetrapeptide considered one of the most promising longevity peptides.
Evidence Level

The most researched copper peptide for skin rejuvenation and hair growth.
Evidence Level

Growth-hormone-releasing peptide that boosts GH and appetite; commonly stacked with a GHRH like CJC-1295.
Evidence Level

Mitochondrial-derived peptide studied for cytoprotection, metabolic health, and longevity signaling.
Evidence Level

The beginner-friendly GHRP for sleep quality, recovery, and anti-aging.
Evidence Level

Orally active ghrelin-receptor agonist that raises GH and IGF-1 around the clock, no injection required.
Evidence Level

Mitochondrial-derived peptide that improves insulin sensitivity, metabolic flexibility, and exercise capacity.
Evidence Level

Essential cellular coenzyme used to support energy metabolism, DNA repair, and healthy aging.
Evidence Level

Next-generation triple agonist (GLP-1 / GIP / glucagon) producing the largest weight-loss results seen in trials to date.
Evidence Level

The widely studied GLP-1 agonist behind modern weight-loss medicine, strong appetite control and metabolic benefits.
Evidence Level

Classic GHRH peptide that gently stimulates the body's own growth-hormone release for sleep, recovery, and anti-aging.
Evidence Level

Mitochondria-targeting peptide researched for cellular energy, cardiac function, and age-related decline.
Evidence Level

GLP-1 / glucagon dual agonist studied for weight loss and metabolic-associated fatty liver disease (MASH).
Evidence Level

GHRH analogue clinically proven to reduce visceral (deep belly) fat and improve body composition.
Evidence Level

Immune-modulating peptide that helps regulate T-cell function and resilience to infection.
Evidence Level

Dual GLP-1 / GIP agonist for powerful appetite suppression, blood-sugar control, and fat loss.
Evidence Level
Cycling schedules, IV vs subcutaneous guidance, and stacking protocols are available with a subscription.
Start Free Trial7 days free. Then $24/month.
PepCompass provides educational information only. Nothing on this platform constitutes medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.